ClinicalTrials.Veeva

Menu

The Impact of Preoperative Supplementation of Zinc

Cairo University (CU) logo

Cairo University (CU)

Status

Completed

Conditions

Nutrition Disorders
Surgery

Treatments

Dietary Supplement: Zinc

Study type

Interventional

Funder types

Other

Identifiers

NCT05785013
MS 277-2022

Details and patient eligibility

About

  1. Pre operative anthropometric assessment including : weight in kg, height/length and BMI
  2. Pre operative Zinc supplementation (dose according to the age) for 7 days preoperatively for cases
  3. Postoperative data collection

Full description

Postoperative data collection :

  • Length of hospital stay
  • Complication and sorting of them
  • Lab withdrawal of inflammatory markers on 2-3 day postoperatively

Enrollment

1 patient

Sex

All

Ages

1 month to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. All children patients with Hirschsprung disease admitted for surgical intervention with different ( age , sex )
  2. Type of surgery : transanal pull through
  3. Whose parents or caregivers approve for the participation in the study

Exclusion criteria

  1. Patients with emergency situations
  2. Whose parents or caregivers will not apply for the participation in the study

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

1 participants in 2 patient groups

Interventional
Experimental group
Description:
25 children diagnosed with Hirschsprung disease and planned for elective surgery will be supplemented with Zinc 7 days before the operation . Outcomes will be evaluated thorugh measuring the hospital length stay. Other parameters including inflammatory markers as CRP , CRP /albumin ratio and development of postoperative complications will be assesed and compared between cases and controls
Treatment:
Dietary Supplement: Zinc
Control
No Intervention group
Description:
25 children diagnosed with Hirschsprung disease and planned for elective surgery will recieve the standard care provided for the cases and will not be supplemented with Zinc . Outcomes will be evaluated thorugh measuring the hospital length. Other parameters including inflammatory markers as CRP , CRP /albumin ratio and development of postoperative complications will be assesed and compared between cases and controls

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems